Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

2924 with DOI

8 strong · 16 moderate · 5 weak

Compilations

12026-05-07T16:30:12.095Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

30last ruled 2026-06-04

0 awaiting a ruling

Issued documents

42026-10-19T20:29:00.134Z

notice · info card · emergency

Searches

214 with no results

queries and counts on the build

Claims checked

6345 supported

45 supported · 18 not

Correspondence

0received

consent field ships in Phase 4

Edges

219

derivations recorded for this entity

Complete over 29 sources, 1 compilation, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/2-fea/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-09-07srcScreening of Astec CHIRALDEX G-PN and LIPODEX D gas chromatography columns for enantioseparation of amphetamine derivatives
  3. 2026-09-07src4-Fluoroamphetamine (4-FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis
  4. 2026-09-07srcPharmacology of Drugs Used as Stimulants
  5. 2026-09-07srcPharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
  6. 2026-09-07srcMethamphetamine-induced cardiotoxicity: in search of protective transcriptional mechanisms
  7. 2026-09-07srcOpioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
  8. 2026-09-07srcDrug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine
  9. 2026-09-07srcIdentification and characterization of the new psychoactive substance 3-fluoroethamphetamine in seized material
  10. 2026-09-07srcOverdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.
  11. 2026-09-07srcLeakage of the blood-brain barrier followed by vasogenic edema as the ultimate cause of death induced by acute methamphetamine overdose
  12. 2026-09-07srcEffect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service
  13. 2026-09-07srcMonoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones
  14. 2026-09-07srcSerotonin toxicity involving MDMA (ecstasy) and moclobemide
  15. 2026-09-07srcExcretion of 4-fluoroamphetamine and three metabolites in urine after controlled oral ingestion
  16. 2026-09-07srcLocomotor and discriminative stimulus effects of fluorinated analogs of amphetamine and methamphetamine in mice and rats
  17. 2026-09-07srcStructure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones.
  18. 2026-09-07srcMDMA interactions with pharmaceuticals and drugs of abuse
  19. 2026-09-07srcIdentification and Quantitative Analysis of 2-Fluoromethamphetamine and Its Metabolites in Human Urine
  20. 2026-09-07srcNovel Phenethylamines and Their Potential Interactions With Prescription Drugs: A Systematic Critical Review
  21. 2026-09-07srcComparative studies on enantioseparation of New Psychoactive Substances using cyclodextrin-assisted capillary electrophoresis with UV detection
  22. 2026-09-07srcSafety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans
  23. 2026-09-07srcAmphetamine Derivatives as Monoamine Oxidase Inhibitors
  24. 2026-09-07srcPara-Halogenation of Amphetamine and Methcathinone Increases the Mitochondrial Toxicity in Undifferentiated and Differentiated SH-SY5Y Cells
  25. 2026-09-07srcInvestigation of MDMA Inhibitory Effect on CytochromeP450 3A4 in Isolated Perfused Rat Liver Model Using Tramadol
  26. 2026-09-07srcHuman pharmacology of MDMA: pharmacokinetics, metabolism, and disposition
  27. 2026-09-07srcTherapeutic potential of monoamine transporter substrates
  28. 2026-09-07srcN-ethyl-1-(2-fluorophenyl)propan-2-amine discussion thread
  29. 2026-09-07srcCayman Chemical: 2-Fluoroethamphetamine (hydrochloride) - Item 25266
  30. 2026-09-07src2-FEA - PsychonautWiki
  31. 2026-09-04issueIssued emergency
  32. 2026-09-04issueIssued info_card
  33. 2026-09-04issueIssued notice
  34. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  35. 2026-06-04publicationPublication — backfill
  36. 2026-05-07revisionRevision 1
  37. 2026-05-07absenceSearched PubMed for "3-fluoroethamphetamine identification characterization seized material NPS" — no results
  38. 2026-05-07absenceSearched PubMed for "2-FEA 2-fluoroethylamphetamine fluorinated amphetamine pharmacology" — no results
  39. 2026-05-07absenceSearched PubMed for "fluoroamphetamine pharmacokinetics half-life human plasma" — no results
  40. 2026-05-07absenceSearched PubMed for "fluorinated amphetamine monoamine releasing agent dopamine norepinephrine" — no results
  41. 2026-05-07genGeneration — pipeline-v5 · with 3 morepipeline-v5
  42. 2026-05-07rungeneration run

The same entries, as forms: six forms.